29 May 2025 in Chemical Engineering Journal
BABeatriz Altamira-Algarra
+2
27 February 2026 in SSRN Electronic Journal
This study reports, for the first time, a stable and reproducible semi-continuous bioprocess for the sustained production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) over 98 days, corresponding to 7 consecutive operational repetitions. The process was operated under non-sterile conditions using a cyanobacteria-dominated microbiome and employed acetate and valerate supplementation. Throughout the operation, a consistent 3-hydroxyvalerate (3HV) molar fraction of 8-12.2 mol% was maintained, with a maximum polymer content of 17.9% of dry cell weight. Notably, reducing the valerate concentration from 100 to 50 mg·L-1 did not compromise PHBV production, indicating a robust metabolic adaptation of the microbial consortium and highlighting the potential for substrate optimization. Microbial community analysis revealed a strong dominance of Synechocystis sp. (>95%) over Synechococcus sp. (<5%), with the consortium exhibiting high resilience to cyclic hypoxic conditions. Transmission electron microscopy, in combination with Nile blue staining, confirmed the intracellular accumulation of PHBV granules within the microbial cells. Thermal characterization further demonstrated the formation of semi-crystalline PHBV, with characteristic melting transitions spanning 147.41-169.77 °C. Overall, this work demonstrates a robust, scalable biological platform for the continuous production of PHBV with controlled composition and stable thermal properties, thereby contributing to the development of sustainable biopolymer production processes.